[End-of-life therapy for patients dying with cancer: a retrospective database study]

Wien Med Wochenschr. 2018 Oct;168(13-14):344-349. doi: 10.1007/s10354-018-0631-5. Epub 2018 Mar 13.
[Article in German]

Abstract

Background: The topic of "medical oversupply at the end-of-life" is being discussed intensively internationally. The aim of this paper is to present the data of end-of-life care in one region in Austria (Lower Austria).

Methods: The data basis for the end-of-life indicators was the routine data (secondary data analysis) of the Lower Austrian District Health Insurance Fund (NÖGKK) from 2015. The basic population consisted of persons with inpatient hospitalization with a cancer diagnosis. Primary endpoints included place of death and time of death, hospital admission, and special end-of-life therapies (30 days before death). NÖGKK insured persons older than 16 years and a subpopulation older than 65 years were evaluated.

Results: 2788 cancer patients (NÖGKK insured) were included. 61.1% died in a hospital, 17.9% of them on the day of admission. In 16.2% of all patients, death occurred on a palliative care unit, 9.3% died in an intensive care unit. The hospitalization rate 30 days before death was 61.6%. Hospital admission was more common in men than in women. 9.4% of total deaths received chemotherapy, radiotherapy, or monoclonal antibodies within the last 30 days.

Conclusions: In international comparison, the region of Lower Austria shows very high hospital admission and hospital mortality rates. Further investigations for the entire country (all regions) are therefore desirable. The establishment of a discussion about the medical oversupply at the end-of-life in Austria, including appropriate care concepts and care models, is needed.

Keywords: Cancer; Chemotherapy; Hospitalization; Mortality; Radiotherapy; Terminal care.

MeSH terms

  • Austria
  • Female
  • Hospitalization
  • Humans
  • Male
  • Neoplasms*
  • Palliative Care
  • Retrospective Studies
  • Terminal Care*